References
- Winters C J, Sallman A L, Baker B J, Meadows J, Rico D M, Vesely D L. The N-terminus and a 4,000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure. Circulation 1989; 80: 438–49
- Lerman A, Gibbons R J, Rodeheffer R J, Bailey K R, McKinley L J, Heublein D M. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 1993; 341: 1105–9
- Winters C J, Sallman A L, Vesely D L. Circardian rhythm of prohormone atrial natriuretic peptides 1–30 31–67 and 99–126 in man. Chronobiol Internat 1988; 5: 403–9
- Vesely D L, Kanabrocki E L, Sothern R B, Scheving L E, Tsai T H, Greco J. The circadian rhythm of the N-terminus and C-terminus of the atrial natriuretic factor prohormone. Chronobiol Internat 1990; 7: 51–7
- Glembotski C C, Dixon J E, Gibson T R. Secretion of atrial natriuretic factor (1–98) by primary cardial myocytes. J Biol Chem 1988; 263: 16073–81
- Sundsfjord J A, Thibault G, Larochelle P, Cantin M. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab 1988; 66: 605–10
- Vesely D L, Norris J S, Walters J M, Jespersen R R, Bayerns D A. Atrial Natriuretic prohormone peptides 1–30 31–67 and 79–98 vasodilate the aorta. Biochem Biophys Res Commun 1987; 148: 1540–48
- Devahane J B, Martin D R, Thigg D J, Winters C J, Vesely D L, Buerhart J E. Prohormone atrial natriuretic peptide (31–67) as well as atrial natriuretic factor causes a marked natriuresis. Clin Res 1989; 37: 583
- Raine AEG, Erne P, Bürgisser E, Müller F B, Bolli P, Burkart F. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 1986; 315: 533–7
- Burnett J C, Kao P C, Hu D C, Heser D W, Heublein D, Granger J P. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 1986; 231: 1145–7
- Baker B J, Wu WCL, Winters C J, Dinh H, Wyeth R, Sallman A L. Exercise increases the circulating concentration of the N-terminus of the atrial natriuretic factor prohormone in normal individuals. Am Heart J 1991; 122: 1395–402
- Anderson J V, Millar N D, O'Hare J P, Mackenzie J C, Corrall R J, Bloom S R. Atrial natriuretic peptide: physiological release associated with natriuresis during water immersion in man. Clin Sci 1986; 71: 319–22
- Lang R E, Tholken H, Ganten D, Luft F C, Ruskoaho H, Unger T. Atrial natriuretic factor: A circulating hormone stimulated by volume loading. Nature 1985; 314: 264–6
- Shenker Y, Sider R S, Ostafin E A, Grekin R J. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. J Clin Invest 1985; 76: 1784–7
- Armitage P, Berry G. Statistical methods in medical research. 2nd edn. Blackwell Scientific Publications, Oxford 1987
- Gardner J M, Altman D G. Statistics with confidence. British Medical Journal, London 1989
- De Simone G, Devereux R B, Roman M J, Ganau A, Chien S, Alderman M H. Gender differences in left ventricular anatomy blood viscosity and volume regulatory hormones in normal adults. Am J Cardiol. 1991; 68: 1704–8
- Wallén T, Landahl S, Hedner T, Hedner J, Hall C. Atrial peptides ANP(1–98) and ANP(99–126) in health and disease in an elderly population. Eur Heart J 1993; 14: 1508–13